+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Amines 86770-76-5
86770-76-5,MFCD21609490
Catalog No.:AA004N0L

86770-76-5 | 1-Phenyl-2,5,8,11-tetraoxatridecan-13-amine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
95%
in stock  
$20.00   $14.00
- +
1g
95%
in stock  
$71.00   $50.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA004N0L
Chemical Name:
1-Phenyl-2,5,8,11-tetraoxatridecan-13-amine
CAS Number:
86770-76-5
Molecular Formula:
C15H25NO4
Molecular Weight:
283.3633
MDL Number:
MFCD21609490
SMILES:
NCCOCCOCCOCCOCc1ccccc1
Properties
Properties
 
BP:
390.4±32.0°C at 760 mmHg  
Form:
Liquid  
Storage:
Inert atmosphere;2-8℃;  

Computed Properties
 
Complexity:
198  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
20  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
13  
XLogP3:
0.2  

Upstream Synthesis Route

[1]Patent:WO2007/112100,2007,A2,.Locationinpatent:Page/Pagecolumn103;131

[2]TetrahedronLetters,1983,vol.24,#15,p.1609-1610

[3]EuropeanJournalofMedicinalChemistry,2015,vol.102,p.153-166

[4]JournaloftheAmericanChemicalSociety,1994,vol.116,#12,p.5057-5062

[1]JournaloftheAmericanChemicalSociety,1994,vol.116,#12,p.5057-5062

[2]EuropeanJournalofMedicinalChemistry,2015,vol.102,p.153-166

[1]JournaloftheAmericanChemicalSociety,1994,vol.116,#12,p.5057-5062

[2]EuropeanJournalofMedicinalChemistry,2015,vol.102,p.153-166

[1]JournaloftheAmericanChemicalSociety,1994,vol.116,#12,p.5057-5062

[1]EuropeanJournalofMedicinalChemistry,2015,vol.102,p.153-166

Downstream Synthesis Route
86770-76-5    154715-61-4   
N-(2-{2-2-(2-Benzyloxy-ethoxy)-ethoxy-ethoxy}-ethyl)-4-sulfamoyl-benzamide 

[1]JournaloftheAmericanChemicalSociety,1994,vol.116,p.5057-5062

[1]MedChemComm,2019,vol.10,p.1037-1041

[2]Patent:WO2007/112100,2007,A2.Locationinpatent:Page/Pagecolumn103;131

[3]TetrahedronLetters,1983,vol.24,p.1609-1610

[4]EuropeanJournalofMedicinalChemistry,2015,vol.102,p.153-166

[5]JournaloftheAmericanChemicalSociety,1994,vol.116,p.5057-5062

951260-46-1    86770-76-5   
C167H230F27N15O51 

[1]Patent:WO2007/112100,2007,A2.Locationinpatent:Page/Pagecolumn102-103

[2]Patent:WO2007/112100,2007,A2.Locationinpatent:Page/Pagecolumn104;106-107

C79H86F27N15O51 
  86770-76-5   
C319H454F27N31O99 

[1]Patent:WO2007/112100,2007,A2.Locationinpatent:Page/Pagecolumn106-107

112-60-7   
compoundofBF3withmethanol 
  86770-76-5 

[1]JournaloftheAmericanChemicalSociety,1994,vol.116,p.5057-5062

Literature

Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 86770-76-5
2050-25-1

2050-25-1

 24342-68-5

24342-68-5

 57671-28-0

57671-28-0

 55489-58-2

55489-58-2

 86259-87-2

86259-87-2

 868594-48-3

868594-48-3
Building Blocks
More >
Tags:86770-76-5 Molecular Formula|86770-76-5 MDL|86770-76-5 SMILES|86770-76-5 1-Phenyl-2,5,8,11-tetraoxatridecan-13-amine